News
Ready-to-Dilute Pemfexy Gains Additional NSCLC Indication
The ready-to-dilute formulation was developed to eliminate the reconstitution step with Alimta.
Your search for non small cell lung cancer returned 4 results
News
Krazati Approved for KRASG12C-Mutated Locally Advanced or Metastatic NSCLC
Krazati is a highly selective and potent oral small molecule inhibitor of KRASG12C.
News
Imjudo Plus Imfinzi and Chemotherapy Approved for Metastatic NSCLC
The approval was based on data from a phase 3 POSEIDON study.
News
Libtayo Plus Chemotherapy Approved as First-Line Treatment for Advanced NSCLC
Findings showed that treatment with cemiplimab-rwlc plus platinum-based chemotherapy demonstrated a statistically significant improvement in overall survival.
